209 related articles for article (PubMed ID: 26249215)
21. Female sex hormone receptors in gallbladder cancer.
Saranga Bharathi R; Singh R; Gupta R; Verma GR; Kalra N; Kiran K; Joshi K
J Gastrointest Cancer; 2015 Jun; 46(2):143-8. PubMed ID: 25772307
[TBL] [Abstract][Full Text] [Related]
22. Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.
Song HW; Chen C; Shen HX; Ma L; Zhao YL; Zhang GJ; Geng ZM; Wang L
J Surg Oncol; 2015 Nov; 112(6):677-80. PubMed ID: 26458491
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of CD109 expression in myxofibrosarcoma.
Emori M; Tsukahara T; Murata K; Sugita S; Sonoda T; Kaya M; Soma T; Sasaki M; Nagoya S; Hasegawa T; Wada T; Sato N; Yamashita T
J Surg Oncol; 2015 Jun; 111(8):975-9. PubMed ID: 26031650
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of adenosquamous/squamous cell carcinoma of the gallbladder.
Kim WS; Jang KT; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2011 Mar; 103(3):239-42. PubMed ID: 21337551
[TBL] [Abstract][Full Text] [Related]
25. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.
Li J; Yang Z; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Clin Transl Oncol; 2014 Feb; 16(2):200-7. PubMed ID: 23793810
[TBL] [Abstract][Full Text] [Related]
26. EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.
Yuan Y; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF; Zeng GX; Chen SL
Asian Pac J Cancer Prev; 2014; 15(3):1441-6. PubMed ID: 24606480
[TBL] [Abstract][Full Text] [Related]
27. Hepatopancreatoduodenectomy for squamous and adenosquamous carcinoma of the gallbladder.
Miyazaki K; Tsutsumi N; Kitahara K; Mori M; Sasatomi E; Tokunaga O; Hisatsugu T
Hepatogastroenterology; 1995 Feb; 42(1):47-50. PubMed ID: 7782034
[TBL] [Abstract][Full Text] [Related]
28. [Proteomic study of gallbladder cancer, with special reference on the expression and significance of annexin A3].
Tan Y; Meng HP; Wu Q; Wang FQ; Wu HR
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):382-6. PubMed ID: 21055154
[TBL] [Abstract][Full Text] [Related]
29. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
30. Adenosquamous/squamous cell carcinoma of the gallbladder.
Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
[TBL] [Abstract][Full Text] [Related]
31. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
Tumour Biol; 2013 Feb; 34(1):359-68. PubMed ID: 23065574
[TBL] [Abstract][Full Text] [Related]
32. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
33. CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
[TBL] [Abstract][Full Text] [Related]
34. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
35. Squamous variant of gallbladder cancer: is it different from adenocarcinoma?
Kalayarasan R; Javed A; Sakhuja P; Agarwal AK
Am J Surg; 2013 Sep; 206(3):380-5. PubMed ID: 23827515
[TBL] [Abstract][Full Text] [Related]
36. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD109 in human cancer.
Hashimoto M; Ichihara M; Watanabe T; Kawai K; Koshikawa K; Yuasa N; Takahashi T; Yatabe Y; Murakumo Y; Zhang JM; Nimura Y; Takahashi M
Oncogene; 2004 Apr; 23(20):3716-20. PubMed ID: 15116102
[TBL] [Abstract][Full Text] [Related]
38. Adenosquamous carcinoma of the gallbladder: a rare entity and dilemmas in its management.
Zishan MA; Tee CL
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37236675
[TBL] [Abstract][Full Text] [Related]
39. CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
Jia W; Ren C; Wang L; Zhu B; Jia W; Gao M; Zeng F; Zeng L; Xia X; Zhang X; Fu T; Li S; Du C; Jiang X; Chen Y; Tan W; Zhao Z; Liu W
Oncotarget; 2016 Aug; 7(34):55328-55342. PubMed ID: 27419372
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
Ren G; Yu G; Liu LW; Ma L
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
